Agostinho Carvalho
LightNews LightNews
agocarvalho.bsky.social
Agostinho Carvalho
@agocarvalho.bsky.social
2.1K followers 290 following 8 posts
🇵🇹 Principal Investigator at ICVS, University of Minho, Portugal. Researcher interested in fungal immunology, lung inflammation, and more...
Posts Replies Media Videos
Reposted by Agostinho Carvalho
iannaconelab.bsky.social
Join us for this exciting meeting! @embo.org Workshop "Pathogen Immunity and Signalling", 8-12 June, 2026, Leiden, The Netherlands meetings.embo.org/event/26-pat...
October 18, 2025 at 6:55 AM
Reposted by Agostinho Carvalho
therad-lab.bsky.social
Looking for something to read with your tea this weekend? Try this new explainer on the #mycobiome! Learn about the 🍄fungi that live in your body, and why this matters for your health. New from me in The Conversation:
#immunosky 🧪

theconversation.com/the-fungi-li...
The fungi living in the body play an important role in health – here’s what you should know about the ‘mycobiome’
The ‘mycobiome’ refers to the hundreds of species of fungi that normally live on and in our body.
theconversation.com
October 18, 2025 at 9:08 AM
Reposted by Agostinho Carvalho
therad-lab.bsky.social
Fancy doing a PhD on #fungi ? 🍄 I'm co-supervising a project on the MIDTP program with Dr Ayesha Rahman - follow the link for project details and how to apply! #FindAPhD #immunosky 🧪
www.birmingham.ac.uk/about/colleg...
Midlands Integrative Biosciences Training Partnership - University of Birmingham
MIBTP is a UK-wide doctoral training programme that equips bioscience PhD students with interdisciplinary skills to tackle global challenges in agriculture, health, and sustainability.
www.birmingham.ac.uk
October 14, 2025 at 1:04 PM
Reposted by Agostinho Carvalho
olivercornely.bsky.social
📢 Save the Date! 🎉
The next TIMM Congress will take place 10–13 September 2027 in Antwerp, Belgium!
We can’t wait to see you there – mark your calendars! 🗓️✨ #TIMM13 #Antwerp2027
October 10, 2025 at 6:15 AM
Reposted by Agostinho Carvalho
icvs-uminho.bsky.social
🔬 Advanced Seminars are back this October at ICVS!
Starting Oct 2 | 1 PM | A0.03 with Bruno Almeida – IPLEXMED: Driving the Next Generation of Diagnostics from Lab to Life.
Don’t miss this month’s top talks on cancer, ALS, climate & more!
#ICVSAdvancedSeminars
September 30, 2025 at 9:23 AM
Reposted by Agostinho Carvalho
icvs-uminho.bsky.social
ICVS will be at the European Researchers' Night 2025!

Join us at Forum Braga on Sept 26, from 2:30 PM to midnight, for experiments, workshops, and more. Come meet our researchers and explore the world of science!
Free entry! #NEI2025 #ICVS #ScienceForAll
September 12, 2025 at 2:22 PM
Reposted by Agostinho Carvalho
ecdc.europa.eu
#JustPublished!
Drug-resistant fungus #CandidozymaAuris is spreading rapidly in European hospitals. #ECDC calls for urgent action.

📈 Cases are rising, outbreaks are larger, and several countries now report local transmission.

Press release: bit.ly/46uR1iK
#CandidaAuris #HAI #IDsky #EpiSky #AMR
Drug-resistant fungus Candidozyma auris confirmed to spread rapidly in European hospitals: ECDC calls for urgent action
The latest survey from ECDC, the fourth of its kind, confirms that Candidozyma auris (formerly Candida auris) continues to spread quickly across European hospitals.
bit.ly
September 11, 2025 at 9:03 AM
Reposted by Agostinho Carvalho
sarah-delliere.bsky.social
✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team!
🔗 bit.ly/46kajHr
@simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
September 4, 2025 at 7:57 AM
Reposted by Agostinho Carvalho
shlezingerlab.bsky.social
🚨 Fungi + viruses + mammalian lungs? Buckle up! Our new paper in
@natmicrobiol.nature.com
uncovers the story of a deadly fungus and its gnarly viral hitchhiker — and how this duo may change how we diagnose & treat fungal disease 🍄🫁🚨 doi.org/10.1038/s415... ⬇️
Aspergillus fumigatus dsRNA virus promotes fungal fitness and pathogenicity in the mammalian host - Nature Microbiology
A mycovirus infecting the pathogenic fungus Aspergillus fumigatus enhances its stress tolerance and virulence in mice.
doi.org
August 14, 2025 at 9:46 AM
Reposted by Agostinho Carvalho
bertuzzilab.bsky.social
We are recruiting two Research Associates! Funded by the
@wellcometrust.bsky.social , join us to work on Mucorales adaption in collaboration with Becky Hall (University of Kent) www.jobs.manchester.ac.uk/Job/JobDetai...
Deadline: 1st October
Research Associate (PDRA) in Fungal Infection Biology :Oxford Road
www.jobs.manchester.ac.uk
August 7, 2025 at 6:50 AM
Reposted by Agostinho Carvalho
pedromorgado.bsky.social
Isto não é uma decisão de um Ministério da Educação que governa de acordo com a evidência técnica e científica.
É uma lamentável cedência populista a quem não se importa de aumentar as gravidezes indesejadas e a vulnerabilidade dos que não têm recursos económicos para aceder à formação essencial.
July 21, 2025 at 1:39 PM
Reposted by Agostinho Carvalho
therad-lab.bsky.social
New BBC article on fungal infections in which we are quoted:
www.bbc.co.uk/future/artic...
Our body is a mosaic of fungi. Some scientists think they could be influencing our brain
The fungi within our bodies may have a much greater effect on our health than we've long given them credit for.
www.bbc.co.uk
July 22, 2025 at 6:44 AM
Reposted by Agostinho Carvalho
i3suporto.bsky.social
🖼️"From Artifacts to Facts"
🗓️21-28Jul 🕗 8h-20h
📍ICBAS-UP, foyer Salão Nobre
🎟️free entrance

The exhibit "From Artifacts to Facts" is a tribute to Prof Teixeira da Silva (1932-2012), legendary #UPorto academic and researcher at the inception of IBMC, one of #i3S founding institutes.
#SciArt #outreach
July 18, 2025 at 3:25 PM
Reposted by Agostinho Carvalho
yspi.bsky.social
We are proud to present ySPI, the newly established youth initiative of the Portuguese Society for Immunology (SPI), approved in April 2025.
The ySPI has been created by and for young scientists.
Our mission is to connect, support students and young researchers who are passionate about immunology.
ySPI logo
July 18, 2025 at 10:53 AM
Reposted by Agostinho Carvalho
swidergall-lab.bsky.social
Check out our new preprint Metabolic imprinting drives epithelial memory during mucosal #fungal infection. Thanks to all collaborators www.biorxiv.org/content/10.1...
Metabolic imprinting drives epithelial memory during mucosal fungal infection
Epithelial cells at barrier sites are emerging as active participants in innate immune memory, yet the underlying metabolic and epigenetic mechanisms remain unclear. Here, we uncover a previously unre...
www.biorxiv.org
July 17, 2025 at 6:21 PM
Reposted by Agostinho Carvalho
sancholab.bsky.social
💥 A gut microbe metabolite that drives #atherosclerosis?
Yes—Imidazole propionate (ImP) triggers vascular inflammation without changing cholesterol.
🧪 We show the pathway—and how to block it.
nature.com/articles/s41... #OpenAccess at
@Nature
@CNIC_CARDIO
#CVD #immunosky #cardiosky #microbiomesky
Imidazole propionate is a driver and therapeutic target in atherosclerosis - Nature
Imidazole propionate produced by gut microbiota is associated with atherosclerosis in mouse models and in humans, and causes the development of atherosclerosis through activation of the imidazoline-1 ...
nature.com
July 16, 2025 at 5:37 PM
Reposted by Agostinho Carvalho
lozanzi.bsky.social
#EpigeneticPower! 💥 #NewPaperAlert! We show @cp-immunity.bsky.social that endogenous oxidized lipids decide whether host survives or dies during #sepsis, #ARDS, or Staph infection! Ox lipids bind & inhibit #AKT, boosting inhibitory H3K27 methylation via EZH2 & blocking #IL10!
Epigenetic silencing of interleukin-10 by host-derived oxidized phospholipids supports a lethal inflammatory response to infections
Upon pathogen detection, phagocytes trigger immunity. This process induces tissue stress and the formation of host-derived molecules that further tune immune responses. We show that host-derived oxidi...
dlvr.it
July 17, 2025 at 3:35 PM
Reposted by Agostinho Carvalho
drianweissman.bsky.social
Fungal infections are getting harder to treat. The fungus Aspergillus fumigatus tops the World Health Organization's list of worrying fungal diseases. It's growing increasingly resistant to the first-line drug used to treat it.
www.nbcnews.com/health/healt...
Fungal infections are getting harder to treat
The fungus Aspergillus fumigatus tops the World Health Organization's list of worrying fungal diseases. It's growing increasingly resistant to the first-line drug used to treat it.
www.nbcnews.com
July 10, 2025 at 2:38 AM
Reposted by Agostinho Carvalho
acasadevall1.bsky.social
Quoted here about the increasing problem of drug resistance in Aspergillus isolates.
www.nbcnews.com/health/healt...
Fungal infections are getting harder to treat
The fungus Aspergillus fumigatus tops the World Health Organization's list of worrying fungal diseases. It's growing increasingly resistant to the first-line drug used to treat it.
www.nbcnews.com
July 9, 2025 at 11:13 PM
Reposted by Agostinho Carvalho
icvs-uminho.bsky.social
🎓 ICVS secures over €2.27M from FCT for 11 research projects in neuroscience, regenerative medicine, infectious diseases & more. A major boost for scientific excellence!
🔗 Learn more: icvs.uminho.pt/icvs-secures...
July 10, 2025 at 9:29 AM
Reposted by Agostinho Carvalho
cmicomms.bsky.social
📣 Next #Communicable drops Mon 14 July!
@angelahuttner.bsky.social & @josh-nosanchuk.bsky.social invite Arturo Casadevall @acasadevall1.bsky.social (Johns Hopkins) to discuss the spread of #fungi due to climate change, and what that means for fungal pathogenesis & infection
#IDSky #clinmicro #MedSky
July 10, 2025 at 10:03 AM
Reposted by Agostinho Carvalho
bertuzzilab.bsky.social
Interested in working on Mucorales adaptation? Thanks to new funding from @wellcometrust.bsky.social, we will have two postdoc and a technician positions advertised very soon! if interested, please get in touch for more information.
July 4, 2025 at 8:59 AM
Reposted by Agostinho Carvalho
martinhoenigl.bsky.social
🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

Groundbreaking work on a very promising new antifungal. Free access here:

authors.elsevier.com/c/1lHca5E-Uo...
authors.elsevier.com
June 18, 2025 at 7:59 AM
Reposted by Agostinho Carvalho
jidjournal.bsky.social
A Functional Polymorphism in IL-36ß Modulates Macrophage Antifungal Effector Functions and Increases Susceptibility to Invasive Pulmonary Aspergillosis

✅ Just Accepted
#IDSky
A Functional Polymorphism in IL-36ß Modulates Macrophage Antifungal Effector Functions and Increases Susceptibility to Invasive Pulmonary Aspergillosis
Genetic predisposition plays a major role in the development of invasive pulmonary aspergillosis (IPA). The risk and course of IPA vary significantly among patients, yet continuously new genetic mechanisms that influence individual antifungal immune responses are being discovered
doi.org
June 12, 2025 at 6:45 PM
Reposted by Agostinho Carvalho
normanvanrhijn.bsky.social
🚨Our latest review in Thorax about the impact of climate change focusing on fungal pathogens in Europe 🌍

A truly enjoyable collaboration with Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social and @mbottery.bsky.social

thorax.bmj.com/content/earl...
June 12, 2025 at 6:08 AM